Abstract
Ceramide is a sphingolipid that acts as a second messenger in signaling systems. Sphingomyelinase generates ceramide in response to cytotoxic stimuli. CCAAT/enhancer binding protein-β (C/EBPβ) and NF-E2-related factor-2 (Nrf2) are both involved in the regulation of the genes encoding phase II detoxification enzymes including glutathione S-transferase (GST). In the present study, we examined the effects of ceramide on C/EBPβ or Nrf2 activation and on the inducible GSTA2 gene transactivation. C2-ceramide (C2), a cell-permeable analog, inhibited GSTA2 induction by oltipraz or tert-butylhydroquinone (t-BHQ) in H4IIE cells, whereas dihydro-C2-ceramide (dihydro-C2), an inactive analog, had no effect. Immunoblot analysis revealed that C2 prevented increase in the level of nuclear C/EBPβ by oltipraz, whereas the level of C/EBPβ in total cell lysates was not changed. Increase in nuclear Nrf2 by t-BHQ was also prevented by C2 treatment. Decreases in nuclear C/EBPβ and Nrf2 by C2 were reversed by treatment of cells with N-benzoyloxycarbonyl (Z)-Leu-Leu-leucinal (MG132), a proteasome inhibitor, verifying the previous observations that the transcription factors were degraded by the proteasome system. In another study, we found that ceramide decreased nuclear hepatic nuclear factor-1 (HNF1), whose binding to the HNF1-response element in the GSTA2 gene was responsible for the constitutive and inducible gene expression. To define the role of C/EBPβ or Nrf2 repression in GST expression under the condition excluding the negative regulation by C2-mediated HNF1 suppression, luciferase activity was determined in the cells transfected with ΔHNF-pGL-1651 plasmid lacking the HNF1-response element. In the cells transfected with ΔHNF-pGL-1651, C2 decreased the luciferase induction by oltipraz or t-BHQ. Thus, ceramide inhibits C/EBPβ or Nrf2 activation, which contributes to repression of GSTA2 gene transactivation.
Footnotes
-
This work was supported by the National Research Laboratory Program (2001), Korea Institute of Science and Engineering Evaluation and Planning, Ministry of Science and Technology, The Republic of Korea.
-
ABBREVIATIONS: PI3-kinase, phosphatidylinositol 3-kinase; ARE, antioxidant response element; C2, C2-ceramide; C/EBP, CCAAT/enhancer binding protein; dihydro-C2, dihydro-C2-ceramide; GST, glutathione S-transferase; HNF1, hepatic nuclear factor-1; HRE, HNF1 response element; Nrf2, NF-E2-related factor-2; t-BHQ, tert-butylhydroquinone; MG132, N-benzoyloxycarbonyl (Z)-Leu-Leu-leucinal; bp, base pair(s); PBS, phosphate-buffered saline; PMSF, phenylmethylsulfonyl fluoride.
- Received January 5, 2004.
- Accepted May 25, 2004.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|